4.2 Article

Acute kidney injury after myeloablative cord blood transplantation in adults: the efficacy of strict monitoring of vancomycin serum trough concentrations

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Increasing Vancomycin Serum Trough Concentrations and Incidence of Nephrotoxicity

Lindsey Pritchard et al.

AMERICAN JOURNAL OF MEDICINE (2010)

Article Medicine, General & Internal

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation.

Ted A. Gooley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Hematology

Incidence and Risk Factors of Early Bacterial Infections after Unrelated Cord Blood Transplantation

Makoto Yazaki et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)

Article Oncology

Early renal injury after myeloablative cord blood transplantation in adults

Hiroshi Mae et al.

LEUKEMIA & LYMPHOMA (2008)

Article Medicine, General & Internal

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity

Levita K. Hidayat et al.

ARCHIVES OF INTERNAL MEDICINE (2006)

Article Immunology

The pharmacokinetic and pharmacodynamic properties of vancomycin

MJ Rybak

CLINICAL INFECTIOUS DISEASES (2006)

Article Urology & Nephrology

Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation

CR Parikh et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2005)

Article Urology & Nephrology

Acute renal failure after myeloablative hematopoietic cell transplant: Incidence and risk factors

SR Hingorani et al.

KIDNEY INTERNATIONAL (2005)

Article Urology & Nephrology

Renal dysfunction in allogeneic hematopoietic cell transplantation

CR Parikh et al.

KIDNEY INTERNATIONAL (2002)